Medicinova, Inc. last reported quarterly results on Feb 20, 2026, for Q4 FY2025 (the quarter ended Dec 31, 2025): revenue of $151,739 and diluted EPS of -$0.06. It usually reports 46–51 days after a quarter ends.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 46–51 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Feb 20, 2026
51 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
0
|
-3
+0.4%
|
-0.06
+0.6%
|
|
Nov 15, 2011
46 days after quarter end
|
—
ended Sep 30, 2011
|
—
|
—
|
—
|
|
Aug 16, 2011
47 days after quarter end
|
—
ended Jun 30, 2011
|
—
|
—
|
—
|
|
May 17, 2011
47 days after quarter end
|
—
ended Mar 31, 2011
|
—
|
—
|
—
|
|
Nov 16, 2010
47 days after quarter end
|
—
ended Sep 30, 2010
|
—
|
—
|
—
|
|
Aug 16, 2010
47 days after quarter end
|
—
ended Jun 30, 2010
|
—
|
—
|
—
|
|
May 17, 2010
47 days after quarter end
|
—
ended Mar 31, 2010
|
—
|
—
|
—
|
|
Nov 12, 2009
43 days after quarter end
|
—
ended Sep 30, 2009
|
—
|
—
|
—
|
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MNOV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- La Jolla, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1226616
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.